Literature DB >> 1173880

Hyperglycemia during acute myocardial infarction. A six-year follow-up study.

M Ravid, M Berkowicz, E Sohar.   

Abstract

Fasting blood glucose (FBG) level and oral glucose tolerance (OGT) were determined in 169 patients within 72 hours of an acute myocardial infarction. Elevated FBG levels were found in 47.5% and a reduced OGT in 72.5%. Of 32 patients who died in the hospital, FBG value was elevated in 72% and the OGT was abnormal in 89%. Of 91 patients who survived longer than six years, the initial FBG level had been elevated in 33%, and the OGT had been abnormal in 67%. Eighty percent of the group with initially raised FBG values had either latent or overt diabetes, while more than 95% of the patients with initially normal FBG values had a normal OGT. Fifty-five percent of the patients with abnormal OGT during myocardial infarction showed normal OGT six years later. The FBG level shortly after an acute myocardial infarction is a better guide to prognosis and to the prediction of subsequent development of diabetes mellitus than the OGT test.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1173880

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  6 in total

1.  A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes.

Authors:  K Foo; J Cooper; A Deaner; C Knight; A Suliman; K Ranjadayalan; A D Timmis
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

Review 2.  Hyperglycemia in nondiabetic patients presenting with acute myocardial infarction.

Authors:  Binita Shah; Nicholas S Amoroso; Steven P Sedlis
Journal:  Am J Med Sci       Date:  2012-04       Impact factor: 2.378

3.  Acute Phase Hyperglycemia among Patients Hospitalized with Acute Coronary Syndrome: Prevalence and Prognostic Significance.

Authors:  Abbas Ali Mansour; Hameed Laftah Wanoose
Journal:  Oman Med J       Date:  2011-03

4.  Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction.

Authors:  Iwan C C van der Horst; Maarten W N Nijsten; Mathijs Vogelzang; Felix Zijlstra
Journal:  Cardiovasc Diabetol       Date:  2007-02-06       Impact factor: 9.951

Review 5.  Review of Systemic Immunosuppression for Autoimmune Uveitis.

Authors:  Claudia Castiblanco; C Stephen Foster
Journal:  Ophthalmol Ther       Date:  2014-03-18

6.  The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome.

Authors:  Xiangyu Zhang; Lini Dong; Qiong Wang; Xiaomei Xie
Journal:  BMC Cardiovasc Disord       Date:  2015-08-25       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.